"I've seen firsthand how successful radiotherapy can be for patients that I treat, but it's been frustrating to see the U.K. lagging behind other countries when it comes to prioritizing research into this vital treatment,” said Dr. Adrian Crellin, Cancer Research UK trustee and former vice president of the Royal College of Radiologists, in a statement. “Cancer Research UK's investment will overhaul radiotherapy research in the U.K. to bring the next generation of treatments to patients sooner."

The entire £56 million has been divided among the centers, with £16.5m awarded to the University of Manchester; £14m to the Cancer Research UK City of London Centre; £8m to the University of Cambridge; and £3.5m each to the Universities of Glasgow, Leeds, and Oxford. The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust have also received £3.5m.

An additional £13 million will be used to form new research groups and fund more Ph.D. students in Manchester, London and Cambridge. The network will also facilitate opportunities for diverse scientific fields to collaborate with one another, with a share of £4 million available to all centers for joint research projects, conferences and temporary assignments between locations.

Back to HCB News

Rad Oncology Homepage